+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 75Years
All Genders
ID07435571

Evaluation of Umbilical Cord Amniotic Membrane Implant in Surgery for Trapeziometacarpal Osteoarthritis to Improve Thumb Function and Reduce Pain

Led by TBF Genie Tissulaire · Updated on 2026-10-06

22

Participants Needed

4

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of a human umbilical cord amniotic membrane allograft as an implant in the surgical treatment of trapeziometacarpal osteoarthritis, a condition causing pain and reduced function in the thumb joint. This Phase 2 study aims to determine if placing this amniotic membrane within the joint can reduce postoperative pain and improve thumb mobility, grip strength, pinch strength, and overall wrist function. Participants will undergo surgery on Day 0 where the treated, devitalized, and sterile umbilical cord amniotic membrane is placed as an interposition implant in the trapeziometacarpal joint. After surgery, participants will attend follow-up visits at 1 month, 3 months, 6 months, and 12 months to assess recovery and joint function. During the study, researchers will measure changes in thumb pain, mobility, and strength, as well as hand strength and wrist daily functionality compared to baseline. They will also monitor the progression of osteoarthritis stage and record any post-surgical complications or implant tolerance issues. Participation includes scheduled assessments and follow-ups over a 12-month period to track these outcomes.

CONDITIONS

Brief Title

Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of Trapeziometacarpal Osteoarthritis

Research Team

L

Laurence BARNOUIN

J

Justine BOSC

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here